Group 3C: Triple Negative Breast Cancer—Metastatic



Thursday, June 9
6:00 pm – 7:30 pm Eastern Time (US/New York)



Mentor: Lynda Weatherby

Lynda Weatherby has been living with Metastatic Breast Cancer since May 2013, and probably for years before that. Her diagnosis of MBC came 12 years after her early-stage diagnosis of “Stage 0 DCIS” and bilateral mastectomy 2001. She was told that “one rogue cell” must have been the cause of the metastatic spread throughout her bones, to her brain, and a very painful facial nerve over a decade after her first diagnosis. Her treatment has included radiation to the spine, two rounds of Gamma Knife radiation to the brain and facial nerve, and continual systemic hormonal treatment since 2013. After progression in 2018-2021, Lynda is on her first chemotherapy now and doing well with a “new normal”.

Lynda is passionate about MBC research and advocacy to make things better for all MBC patients. She is currently serving on the Executive Committee of the MBC Alliance, and on the production team of the Our MBC Life Podcast. She also co-founded and co-chairs the Northwest MBC Conference in Seattle, which will resume as an in-person event September 2022.

Twitter: @lyndaweatherby

Scientist: Amanda Jacobson, Ph.D.

Amanda Jacobson obtained a Ph.D. in cell biology and immunology from the University of Utah, and her post-doctoral work focused on HIV pathogenesis and infant immunology. She has been in the biotech/ pharma space supporting oncology drug development in both blood and solid tumor indications for a little over 10 years. Currently, she is the director of clinical science at a small biotech company supporting clinical trials in breast cancer.